Enibarcimab

DB16730InvestigationalProtein Based Therapies

Enibarcimab is under investigation in clinical trial NCT03989531 (Adrecizumab in Cardiogenic Shock).

Mechanism
Curator reviewed
Also known as
Adrecizumab
Code names
HAM-8101

Resolves to

Compound
UNIIK2IB8MBP1ACAS2305638-98-4
Targets
P35318ADM

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
5Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Enibarcimab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In